Indication
Remus (Tacrolimus USP) ointment—0.03% and 0.1% for adults, and 0.03% for children aged 2 to 15 years—is indicated for short-term and intermittent long-term therapy in patients with moderate to severe atopic dermatitis or vitiligo.
Dosage Strength: 0.03% & 0.1% Ointment
Pack Size: 5gm